Cite
HARVARD Citation
Sone, H. et al. (2020). Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Diabetes, obesity & metabolism. 22 (3), pp. 417-426. [Online].